Issued Patents All Time
Showing 25 most recent of 34 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421312 | Anti-PD-L1 antibodies and antibody-drug conjugates | Byron Hua Kwan, Heather Van Epps, Andrew Waight, Ryan LYSKI | 2025-09-23 |
| 12194321 | Camptothecin conjugates | Ryan LYSKI, Uland LAU | 2025-01-14 |
| 11319526 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Stephen C. Alley, Django Sussman, Dennis Benjamin, Brian E. Toki, Patrick Burke | 2022-05-03 |
| 11116847 | Methylene carbamate linkers for use with targeted-drug conjugates | Robert Kolakowski, Patrick Burke | 2021-09-14 |
| 10787514 | CD33 antibodies and use of same to treat cancer | May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke | 2020-09-29 |
| 10561739 | Targeted pyrrolobenzodiazapine conjugates | Philip Wilson Howard, Patrick Burke, Peter D. Senter | 2020-02-18 |
| 10443035 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Stephen C. Alley, Django Sussman, Dennis Benjamin, Brian E. Toki, Patrick Burke | 2019-10-15 |
| 10329352 | Pyrrolobenzodiazepines and targeted conjugates | Patrick Burke, Philip Wilson Howard | 2019-06-25 |
| 10328084 | Pyrrolobenzodiazepines and targeted conjugates | Patrick Burke, Philip Wilson Howard | 2019-06-25 |
| 9816069 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Stephen C. Alley, Django Sussman, Dennis Benjamin, Brian E. Toki, Patrick Burke | 2017-11-14 |
| 9731030 | β-glucuronide-linker drug conjugates | — | 2017-08-15 |
| 9732084 | Pyrrolobenzodiazepines used to treat proliferative diseases | Philip Wilson Howard, Luke Masterson, Arnaud Tiberghien, Patrick Burke, Peter D. Senter | 2017-08-15 |
| 9713647 | Pyrrolobenzodiazepines and targeted conjugates | Patrick Burke, Philip Wilson Howard | 2017-07-25 |
| 9707301 | Pyrrolobenzodiazepines and targeted conjugates | Patrick Burke, Philip Wilson Howard | 2017-07-18 |
| 9592240 | Targeted pyrrolobenzodiazapine conjugates | Philip Wilson Howard, Patrick Burke, Peter D. Senter | 2017-03-14 |
| 9587019 | CD33 antibodies and use of same to treat cancer | May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke | 2017-03-07 |
| 9526798 | Pyrrolobenzodiazepines and targeted conjugates | Patrick Burke, Philip Wilson Howard | 2016-12-27 |
| 9522194 | Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus | Svetlana O. Doronina, Toni Kline, Peter D. Senter, Damon Meyer | 2016-12-20 |
| 9399073 | Pyrrolobenzodiazepines | Philip Wilson Howard, Arnaud Tiberghien, Patrick Burke | 2016-07-26 |
| 9387259 | Pyrrolobenzodiazepines and targeted conjugates | Patrick Burke, Philip Wilson Howard | 2016-07-12 |
| 9242013 | Targeted pyrrolobenzodiazapine conjugates | Philip Wilson Howard, Patrick Burke, Peter D. Senter | 2016-01-26 |
| 8993326 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | Stephen C. Alley, Django Sussman, Dennis Benjamin, Brian E. Toki, Patrick Burke | 2015-03-31 |
| RE45272 | β-glucuronide-linker drug conjugates | — | 2014-12-02 |
| 8871720 | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus | Svetlana O. Doronina, Toni Kline, Peter D. Senter, Damon Meyer | 2014-10-28 |
| 8697688 | Pyrrolobenzodiazepines used to treat proliferative diseases | Philip Wilson Howard, Luke Masterson, Arnaud Tiberghien, Patrick Burke, Peter D. Senter | 2014-04-15 |